Friday, March 24, 2023


AbbVie Advances Upadacitinib (RINVOQ) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib,...

WIPO Publishes Aquavit’s Methods for Delivering Bioactive Compositions and Formulations to the Skin

Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, announced that the company's technology patent...

Read Magazine’s Weekly Roundup Featuring Rocket Lab, TuneIn, PayQuicker, Debut and more!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial

SQZ Biotechnologies Company, focused on unlocking the full potential of cell therapies, announced that, according to RECIST 1.1 criteria, a confirmed complete response was...

TeselaGen Offers its Starter Edition to Help BioTech Startups Scale Efficiently

TeselaGen Biotechnology Inc, the company developing the AI-enabled Operating System for Biotechnology R&D and Manufacturing, announces the launch of its Starter Edition, a version of...

Hot Topics